Atika Capital Management LLC Reata Pharmaceuticals Inc Transaction History

Atika Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $1.74 Million - $2.32 Million	22,000 New	22,000 $2.24 Million
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $4.8 Million - $6.86 Million	-48,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$78.27 - $151.29 $3.76 Million - $7.26 Million	48,000 New	48,000 $6.79 Million
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $6.41 Million - $11.2 Million	-68,500 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$126.3 - $176.56 $1.71 Million - $2.38 Million	-13,500 Reduced 16.46%	68,500 $10.7 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $2.42 Million - $4.83 Million	19,500 Added 31.2%	82,000 $11.8 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $4.66 Million - $13.6 Million	62,500 New	62,500 $12.8 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.